Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rig/PBLS added more 2day under.018 :)
Rig/CESV great job!! nicely done
keep an eye on CNCN
AURC/lookin for a money putt
AURC added @.20
SLNC 170k buy wowser
UAMA ask reeeaaallly thin
amen,DC,SLNC nice mover,ask gettin thin
GFCI get out the whip!!!
gmRig/big weeeeeGFCI !!!!
have a great wkd all!!!
KNOS..104/.105
84k buy SLNC nice
FANC is gone on KNOS should run now.095/.10
slnc..gappah please
UAMA :)
roger that/Rig
SLNC?Rig just got back,took care of ol' WDCO
SLNC breaks.15/will be sweet
good vol.7x
SLNC breaks .15 its party time
cheap here u will see
mrgood./FDEG i have .03/50dma
some o'dat good ol' volume wouldn't hurt either
Rig,agree nice chart/GFCI
Rig/GFCI a break of .25 would be a start IMO
get interesting after that
LBTN/grabbed a bunch down here
level2 lookin better also
GWNI, gotta break .05 clean
ETLC .07/.075 10x1
Merci's RSTN bustin 200dma
RSTN/great call Merci
NMGC..thats what i call a gap!!!
Rig/QOIL agree..got the big mo' i think
QOIL :) gm all
QOIL/Rig lets break 50dma here continue
QOIL added on break of 200,looks good
IHITF/beauty,Rigs!!!!congrats
when can we start the weeeeeeeeeeeeeee's
LBTN Lifeline Biotechnologies Reduces Debt By $250,000
RENO, Nev.--(Business Wire)--Dec. 7, 2005--
Lifeline Biotechnologies, Inc. (Pink Sheets: LBTN)
announced today that the Company will reduce their debt by
approximately $250,000 by forgiving past salaries owed to management.
These reductions will be ongoing, equivalent to an annual Company
savings of approximately $150,000 to $200,000 in operating expenses.
This is a first step in a process designed to increase shareholder
value. Additionally, Lifeline Biotechnologies' management is retiring
approximately 51 Million Shares and will reissue stock options at .05
cents per share.
Due to the increase in the outstanding shares, as a result of
shares having been issued principally to acquire financing required
for operations and product development, the company has committed to a
program designed to enhance shareholder value through a comprehensive
strategy, starting with the reduction of the Company's debt. The debt
reduction will enable Lifeline to better implement their business
strategy.
"We believe that this reduction of debt will add substantial
value for our shareholders," said Jim Holmes, CEO of Lifeline
Biotechnologies, Inc. "This is the first step in a restructuring
process. This reduction of debt and stock retirement is designed to
also compensate for any additional shares that may be issued in order
to continue funding the Company. We firmly believe that this is in the
best interests of both our shareholders and the company."
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. is a company with innovative
medical technologies committed to the improvement of the quality of
life through exceptional health care systems. These technologies focus
on assisting in the prevention and early detection of a number of
disease conditions. The company's Cancer Detection technologies deal
with cutting edge innovation to assist practicing physicians in the
delivery of quality medical care. The MastaScope(TM) is used in the
assisting of the early detection of cancer and other abnormalities of
the breast. The MastaScope(TM) has completed development and has
entered the marketplace in the US and internationally. The First
Warning System(TM) for assisting in the early detection of breast
cancer and the OvaScope(TM) for assisting in the early detection of
ovarian cancer are continuing to be developed by the company. More
information is available at the company's website: www.lbti.com.
Safe Harbor
This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 27E
of the Securities Act of 1934. Statements contained in this release
that are not historical facts may be deemed to be forward-looking
statements. Investors are cautioned that forward-looking statements
are inherently uncertain. Actual performance and results may differ
materially from that projected or suggested herein due to certain
risks and uncertainties including, without limitation, ability to
obtain financing and regulatory and shareholder approval for
anticipated actions.
Big Apple Consulting USA, Inc. for Lifeline
Biotechnologies, Inc.
Matt Maguire, 407-884-0444 or 1-866-THE-APPLE
Copyright Business Wire 2005
07Dec05 13:30 GMT
Symbols:
us;LBTN
Source BW Business Wire
Categories:
MST/I/BTC MST/I/MDV MST/L/EN MST/R/NME MST/R/US MST/R/US/NV TGT/BWB
absolutely
ETLC gave me only 10k @.085
then schb moved off to .13
ETLC bid gettin stronger